Paediatrics Anaesthesia
Conditions
Interventions
Intranasal Sedation with ketamine
intranasal Midazolam sedation
intranasal combination of ketamine and midazolam sedation
Sponsors
BEAUTY NAA YARLEY ANNAN
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria I. All participants whose parents or guardians, during the period of the study give their signed or thumb-printed informed consent to participate. II. Infants weighing not more than ten (10) kilograms. III. American Society of Anaesthesiology (ASA) I and II physical status (see Appendix 7).
Exclusion criteria
Exclusion criteria: Exclusion Criteria I. Children with anomalies of the cardiovascular system. II. Children with known allergy or hypersensitive reaction to midazolam or ketamine. III. Presence of otorhinolaryngeal diseases (e.g., rhinitis, nasal polyposis) IV. Children with upper respiratory tract infection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary end-point of the study will be adequate pre-procedural and procedural sedation to complete the scan study | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints included acceptance of IV cannulation, the ease of separation from parents, haemodynamic effects on blood pressure, heart rate and respiratory rates changes and the incidence of complications. Other secondary outcomes of interest were sedation onset time, recovery time and number of failed sedations. | — |
Countries
Ghana
Contacts
Public ContactBEAUTY ANNAN
SENIOR RESIDENT
Outcome results
None listed